
Bloomberg Businessweek Weekend - May 24th, 2024
Bloomberg Businessweek
00:00
Challenges and Transitions in Genetic Testing
Exploring the transition of 23andMe from mass market genetic testing to complex genetic analysis, highlighting challenges in interpreting genetic data, adoption of polygenic risk scores, and financial considerations amidst costly treatments for rare genetic diseases.
Play episode from 35:33
Transcript


